Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

BACKGROUND: Health‐related quality of life (HRQL) is often diminished in patients with ulcerative colitis. AIM: To evaluate the effects of vedolizumab on HRQL in patients with ulcerative colitis. METHODS: Using maintenance phase data from the GEMINI 1 study, an analysis of covariance model was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Feagan, B. G., Patel, H., Colombel, J.‐F., Rubin, D. T., James, A., Mody, R., Lasch, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215718/
https://www.ncbi.nlm.nih.gov/pubmed/27859410
http://dx.doi.org/10.1111/apt.13852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215718/
https://www.ncbi.nlm.nih.gov/pubmed/27859410
http://dx.doi.org/10.1111/apt.13852

Ejemplares similares